Drug development concerning metallo-β-lactamases in gram-negative bacteria

X Li, J Zhao, B Zhang, X Duan, J Jiao, W Wu… - Frontiers in …, 2022 - frontiersin.org
β-Lactams have been a clinical focus since their emergence and indeed act as a powerful
tool to combat severe bacterial infections, but their effectiveness is threatened by drug …

An overview on biological activities of oxazole, isoxazoles and 1, 2, 4-oxadiazoles derivatives

R Gujjarappa, S Sravani, AK Kabi, A Garg… - … : basic structures and …, 2022 - Springer
Heterocyclic compounds containing the oxazole, isoxazole and oxadiazoles rings have
received significant consideration as they perform like a link between life sciences and …

N-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases

C Kaya, J Konstantinović, AM Kany… - Journal of Medicinal …, 2022 - ACS Publications
Drug-resistant pathogens pose a global challenge to public health as they cause diseases
that are extremely difficult to cure. Metallo-β-lactamases (MBLs) are a diverse set of zinc …

Visible‐Light‐Mediated Photocatalytic Synthesis of 2‐Substituted Oxazole‐5‐carbaldehydes Promoted by Benzeneseleninic Acid

L Abenante, GT Quadros, G Perin… - European Journal of …, 2022 - Wiley Online Library
Benzeneseleninic acid was used under visible light irradiation (white LEDs) to promote the
oxidative cyclization of N‐propargyl amides to the respective 2‐substituted oxazole‐5 …

Drug repurposing of the unithiol: inhibition of metallo-β-lactamases for the treatment of carbapenem-resistant gram-negative bacterial infections

VG Grigorenko, MG Khrenova, IP Andreeva… - International journal of …, 2022 - mdpi.com
The increasing antibiotic resistance is a clinical problem worldwide. Numerous Gram-
negative bacteria have already become resistant to the most widely used class of …

Identification of a potential inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) using in silico and in vitro approaches

G Muteeb, MT Rehman, MF AlAjmi, M Aatif, M Farhan… - Molecules, 2022 - mdpi.com
New Delhi metallo-β-lactamase-1 (NDM-1), expressed in different Gram-negative bacteria,
is a versatile enzyme capable of hydrolyzing β-lactam rings containing antibiotics such as …

Risedronate and methotrexate are high-affinity inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): a drug repurposing approach

G Muteeb, A Alsultan, M Farhan, M Aatif - Molecules, 2022 - mdpi.com
Bacteria expressing New Delhi metallo-β-lactamase-1 (NDM-1) can hydrolyze β-lactam
antibiotics (penicillins, cephalosporins, and carbapenems) and, thus, mediate multidrug …

The Effects of One-Point Mutation on the New Delhi Metallo Beta-Lactamase-1 Resistance toward Carbapenem Antibiotics and β-Lactamase Inhibitors: An In Silico …

VT Tran, VH Tran, DN Nguyen, TGS Do, TP Vo… - International Journal of …, 2022 - mdpi.com
Antibiotic resistance has been becoming more and more critical due to bacteria's evolving
hydrolysis enzymes. The NDM-1 enzyme could hydrolyze not only carbapenems but also …

Development of phosphorus-containing metallo-β-lactamase inhibitors: Synthesis and binding studies by solution NMR and molecular docking

K Palica - 2022 - diva-portal.org
Development of phosphorus-containing metallo-β-lactamase inhibitors : Synthesis and
binding studies by solution NMR and molecular docking diva-portal.org Digitala …

[HTML][HTML] Towards combating antibiotic resistance by exploring the quantitative structure-activity relationship of NDM-1 inhibitors

T Yu, AA Malik, N Anuwongcharoen… - EXCLI …, 2022 - ncbi.nlm.nih.gov
Abstract The emergence of New Delhi metallo-beta-lactamase-1 (NDM-1) has conferred
enteric bacteria resistance to almost all beta-lactam antibiotics. Its capability of horizontal …